Cardiovascular Systems, Inc. (CSII) News

Cardiovascular Systems, Inc. (CSII): $36.59

0.32 (+0.88%)

POWR Rating

Component Grades













Filter CSII News Items

CSII News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

CSII News Highlights

  • For CSII, its 30 day story count is now at 8.
  • Over the past 18 days, CSII's stories per day has been in a clear downtrend, falling by about 0.50 per 4 days.
  • The most mentioned tickers in articles about CSII are OAS, ST and MD.

Latest CSII News From Around the Web

Below are the latest news stories about Cardiovascular Systems Inc that investors may wish to consider to help them evaluate CSII as an investment opportunity.

Is Now The Time To Look At Buying Cardiovascular Systems, Inc. (NASDAQ:CSII)?

Cardiovascular Systems, Inc. ( NASDAQ:CSII ), is not the largest company out there, but it received a lot of attention...

Yahoo | September 11, 2021

Cardiovascular Systems (CSII) Down 6.6% Since Last Earnings Report: Can It Rebound?

Cardiovascular Systems (CSII) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | September 3, 2021

Cardiovascular Systems (CSII) Introduces Diamondback in Canada

The introduction of Cardiovascular Systems' (CSII) Diamondback 360 Coronary OAS in Canada will offer physicians an effective treatment option for patients with coronary artery diseases.

Yahoo | August 31, 2021

First Patients in Canada Treated With Cardiovascular Systems, Inc. Diamondback 360® Coronary Orbital Atherectomy System

ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that the first patients in Canada have been treated with its Diamondback 360® Coronary Orbital Atherectomy System (OAS). The first patients in Canada were treated by Sanjog Kalra, MD, Interventional Cardiologist and Cardiac Critical Care P

Business Wire | August 30, 2021

What Do Cardiovascular Systems’ Risk Factors Indicate?

Cardiovascular Systems (CSII) provides medical device solutions for the treatment of vascular and coronary disease. This month, it delivered robust Q4 numbers and also made key changes to its risk factors. Let us take a look at the financial performance of the company and understand what has changed in its key risk factors that investors should know. Cardiovascular Systems’ Q4 revenue jumped 66.8% year-over-year to $71 million, surpassing the Street's consensus by $2 million.

Kailas Salunkhe on TipRanks | August 24, 2021

Atherectomy Devices Market Survey Report Discloses Strategy 2027 Roadmap, Key Players - Cardiovascular Systems Inc. , Medtronic Plc, Spectranetics Corp.

New York, United States: The industry analysis Atherectomy Devices Market report by Decisive Markets Insights includes the market''s key elements like revenue growth, market prognosis (2021-2027), customer preferences, company strategies, performance metrics, COVID-19''s impact on the global market, value chain

OpenPR | August 24, 2021

Breakeven On The Horizon For Cardiovascular Systems, Inc. (NASDAQ:CSII)

We feel now is a pretty good time to analyse Cardiovascular Systems, Inc.'s ( NASDAQ:CSII ) business as it appears the...

Yahoo | August 6, 2021

CSII Reports Smaller-Than-Feared Loss; Revenues Surge 66.8% in Q4

Minnesota-based medical devices firm Cardiovascular Systems (CSII) has reported strong financial results for the fiscal fourth quarter ended June 30. The company develops and sells solutions for the treatment of coronary and vascular diseases. Cardiovascular Systems reported a net loss of $0.14 per share, narrower than the Street’s estimate of a loss of $0.17 per share and the year-ago loss of $0.43 per share. Quarterly revenues surged 66.8% year-over-year to $71 million, exceeding analysts’ expectations of $68.82 million. (See Cardiovascular Systems stock chart on TipRanks) The Chairman, President and CEO of Cardiovascular Systems, Scott Ward, said, “The sustained improvement in the state of the U.S.

Richika Biyani on TipRanks | August 5, 2021

Cardiovascular Systems (CSII) Q4 Loss Narrower Than Expected

Strength in both coronary and peripheral segments drove Cardiovascular Systems' (CSII) revenues in the fiscal fourth quarter.

Yahoo | August 5, 2021

Cardiovascular Systems, inc (CSII) Q4 2021 Earnings Call Transcript

With me today are Scott Ward, CSI Chairman, President and Chief Executive Officer; Rhonda Robb, Chief Operating Officer; and Jeff Points, Chief Financial Officer. During today's call, we will make forward-looking statements.

Yahoo | August 5, 2021

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7006 seconds.